175 related articles for article (PubMed ID: 9651732)
41. A new Ca-antagonist, azelnidipine, reduced blood pressure during exercise without augmentation of sympathetic nervous system in essential hypertension: a randomized, double-blind, placebo-controlled trial.
Arita M; Hashizume T; Tanigawa K; Yamamoto H; Nishio I
J Cardiovasc Pharmacol; 1999 Feb; 33(2):186-92. PubMed ID: 10028925
[TBL] [Abstract][Full Text] [Related]
42. Effect of oxodipine, a novel dihydropyridine calcium channel blocker, in neurogenic hypertensive dogs.
Montastruc P; Montastruc JL; Dubreuil J; Galiano A
Arch Int Pharmacodyn Ther; 1993; 321():57-62. PubMed ID: 8323416
[TBL] [Abstract][Full Text] [Related]
43. Effects of diltiazem retard on ambulatory blood pressure and heart rate variability in patients with essential hypertension.
Kawano Y; Makino Y; Okuda N; Takishita S; Omae T
Blood Press Monit; 2000 Jun; 5(3):181-5. PubMed ID: 10915232
[TBL] [Abstract][Full Text] [Related]
44. Clinical efficacy of efonidipine hydrochloride, a T-type calcium channel inhibitor, on sympathetic activities.
Harada K; Nomura M; Nishikado A; Uehara K; Nakaya Y; Ito S
Circ J; 2003 Feb; 67(2):139-45. PubMed ID: 12547996
[TBL] [Abstract][Full Text] [Related]
45. Long-acting dihydropyridine calcium-channel blockers and sympathetic nervous system activity in hypertension: a literature review comparing amlodipine and nifedipine GITS.
Toal CB; Meredith PA; Elliott HL
Blood Press; 2012 Jul; 21 Suppl 1(Suppl 1):3-10. PubMed ID: 22762301
[TBL] [Abstract][Full Text] [Related]
46. Dihydropyridine calcium channel antagonists in the management of hypertension.
Epstein BJ; Vogel K; Palmer BF
Drugs; 2007; 67(9):1309-27. PubMed ID: 17547473
[TBL] [Abstract][Full Text] [Related]
47. [The effect of calcium channel blockers on activity in the sympathetic nerves, on the vasomotor reflex and on cerebral circulation].
Gan'shina TS; Mirzoian NR
Eksp Klin Farmakol; 1996; 59(5):12-7. PubMed ID: 9026200
[TBL] [Abstract][Full Text] [Related]
48. Amlodipine lowers blood pressure without increasing sympathetic activity or activating the renin-angiotensin system in patients with essential hypertension.
Sasaguri M; Matsumoto N; Noda K; Koga M; Kinoshita A; Ideishi M; Arakawa K
Eur J Clin Pharmacol; 1997; 53(3-4):197-201. PubMed ID: 9476031
[TBL] [Abstract][Full Text] [Related]
49. [Nicardipine attenuates the sympathetic reflex of orthostatism: do dihydropyridine-sensitive calcium channels regulate noradrenaline release?].
Mercuro G; Rossetti ZL; Lai L; Manca MR; Longu G; Ruscazio M; Cherchi A
Cardiologia; 1992 Jul; 37(7):465-7. PubMed ID: 8521422
[TBL] [Abstract][Full Text] [Related]
50. Abnormalities in the regulation of sympathetic activity in human hypertension.
de Champlain J; Cléroux J; Lebeau R; Gonzalez M; Nadeau R
Clin Invest Med; 1987 Nov; 10(6):573-80. PubMed ID: 3326696
[TBL] [Abstract][Full Text] [Related]
51. Acute and chronic calcium antagonist treatment elevates sympathetic activity in primary hypertension.
Lindqvist M; Kahan T; Melcher A; Hjemdahl P
Hypertension; 1994 Sep; 24(3):287-96. PubMed ID: 8082934
[TBL] [Abstract][Full Text] [Related]
52. Comparison of short-acting versus extended-release nifedipine: Effects on hemodynamics and sympathetic activity in patients with stable coronary artery disease.
Parker JD; D' Iorio M; Floras JS; Toal CB
Sci Rep; 2020 Jan; 10(1):565. PubMed ID: 31980638
[TBL] [Abstract][Full Text] [Related]
53. Heart rate in hypertensive patients treated with ACE inhibitors and long-acting dihydropyridine calcium antagonists.
Pierdomenico SD; Bucci A; Lapenna D; Cuccurullo F; Mezzetti A
J Cardiovasc Pharmacol; 2002 Aug; 40(2):288-95. PubMed ID: 12131558
[TBL] [Abstract][Full Text] [Related]
54. Impact of aldosterone receptor blockade compared with thiazide therapy on sympathetic nervous system function in geriatric hypertension.
Wray DW; Supiano MA
Hypertension; 2010 May; 55(5):1217-23. PubMed ID: 20368505
[TBL] [Abstract][Full Text] [Related]
55. Differential activation of cardiac and peripheral sympathetic nervous system by nifedipine: role of pharmacokinetics.
Wenzel RR; Allegranza G; Binggeli C; Shaw S; Weidmann P; Lüscher TF; Noll G
J Am Coll Cardiol; 1997 Jun; 29(7):1607-14. PubMed ID: 9180126
[TBL] [Abstract][Full Text] [Related]
56. [Comment on the information by the Federal Drug and Medical Products Institute on "calcium channel blockers of the 1,4-dihydropyridine class"].
Trenkwalder P
Internist (Berl); 1995 Jul; 36(7):730-1. PubMed ID: 7672923
[No Abstract] [Full Text] [Related]
57. [Lerkanidipin: evolution of dihydropyridine calcium antagonists continues].
Fomin VV; Svistunov AA
Kardiologiia; 2012; 52(11):75-9. PubMed ID: 23237399
[TBL] [Abstract][Full Text] [Related]
58. Acute and long-term effects of beta-adrenergic blockade on blood pressure and sympathetic activity in man [proceedings].
Benedict CR; Pickering TG; Raine AE
J Physiol; 1977 Oct; 271(2):35P-36P. PubMed ID: 21959
[No Abstract] [Full Text] [Related]
59. The use of calcium antagonists in the therapy of hypertension in the elderly.
Israili ZH
Am J Ther; 2003; 10(6):383-95. PubMed ID: 14624275
[TBL] [Abstract][Full Text] [Related]
60. Cardiovascular care with the new T-type calcium channel antagonist: possible role of attendant sympathetic nervous system inhibition.
Bühler FR
J Hypertens Suppl; 1997 Dec; 15(5):S3-7. PubMed ID: 9481610
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
